REQUEST A DEMO
Total
USD $0.00
Search more companies

Astrazeneca Pharma SRL (Romania)

Main Activities: Media Representatives
Full name: Astrazeneca Pharma SRL Profile Updated: August 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Astrazeneca Pharma SRL is a global research-based biopharmaceutical company, focused on discovering, developing and marketing medicines for some of the world’s most serious illnesses, including cancer, heart disease, neurological disorders such as schizophrenia, respiratory disease and infection.

Headquarters
Strada Tipografilor Nr. 1A
Bucharest; Bucharest; Postal Code: 013713

Contact Details: Purchase the Astrazeneca Pharma SRL report to view the information.

Basic Information
Total Employees:
Purchase the Astrazeneca Pharma SRL report to view the information.
Outstanding Shares:
Purchase the Astrazeneca Pharma SRL report to view the information.
Registered Capital:
Purchase the Astrazeneca Pharma SRL report to view the information.
Financial Auditors:
Purchase the Astrazeneca Pharma SRL report to view the information.
Incorporation Date:
April 21, 2008
Key Executives
Purchase this report to view the information.
Administrator
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Astrazeneca Pharma SRL report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RON. Absolute financial data is included in the purchased report.
Net sales revenue
35.71%
Total operating revenue
35.71%
Operating profit (EBIT)
47.37%
EBITDA
54.01%
Net Profit (Loss) for the Period
61.14%
Total assets
34.69%
Total equity
13.26%
Operating Profit Margin (ROS)
0.38%
Net Profit Margin
0.51%
Return on Equity (ROE)
3.15%
Quick Ratio
-0.56%
Cash Ratio
0.33%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?